Tumor Targeting in Cancer Therapy

After many years of vigorous effort, the use of antibodies to target tumors has become highly successful both clinically and commercially. In Tumor Targeting in Cancer Therapy, Dr. Michel Pagé and a panel of authoritative experts from the drug industry, clinics, and academia introduce the principles...

Full description

Bibliographic Details
Other Authors: Pagé, Michel (Editor)
Format: eBook
Language:English
Published: Totowa, NJ Humana 2002, 2002
Edition:1st ed. 2002
Series:Cancer Drug Discovery and Development
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
Table of Contents:
  • I. A Review
  • 1 The Current Status of Tumor Targeting: A Review
  • 2 Clinical Applications of Targeted Therapeutics
  • II. Targeting Tumors with Drug Antibody Conjugates
  • 3 Targeting the CD22 Receptor with RNA Damaging Agents
  • 4 The Development of Liposomes for Enhanced Delivery of Chemotherapeutics to Tumors
  • 5 Overcoming Multiple Drug Resistance with Anti-Pgn Carrier
  • 6 Targeting with Transferrin
  • 7 Synthesis and Evaluation of Paclitaxel Immunoconjugate with Antitumor Activity In Vitro
  • 8 The Use of Drug-Monoclonal Antibody Conjugates for the Treatment of Cancer
  • III. Targeting Tumors with Antibodies
  • 9 Targeting Vascular Endothelium with Antibodies
  • 10 Targeting B-Cell Non-Hodgkin’s Lymphoma with Monoclonal Antibodies
  • 11 From Bench to Bedside: Development of Rituximab (Rituxan®), A Monoclonal Antibody for the Therapy of Non-Hodgkin’s Lymphoma
  • 12 Mylotarg: The First Antibody-Targeted Chemotherapy Agent.
  • IV. Targeting Tumors with Radioimmunoconjugates
  • 13 188Rhenium-Labeled Trisuccin-?CH2HuCC49 as a Radioimmunotherapy Model in Nude Mice
  • V. Targeting Tumors with Immunotoxins
  • 14 General Approach for Targeting Toxins
  • 15 Antibody-Toxin Conjugates: Chemistry of Coupling and Purification
  • 16 Shiga-Like Toxins as Targeted Anticancer Agents
  • VI. Targeting Tumors with Antibody-Enzyme Conjugates (ADEPT)
  • 17 Antibody-Directed Enzyme Prodrug Therapy with Carboxypeptidase G2: Clinical Studies
  • VII. Photodynamic Therapy
  • 18 Photodynamic Therapy: Targeting Cancer Cells with Photosensitizer-Bioconjugates
  • 19 Tumor Targeting Using PEG-m-THPC for Photodynamic Therapy in a Rat Ovarian-Cancer Model
  • VIII. Targeting Tumors with Magnetic Drugs
  • 20 Targeting Tumors with Magnetic Drugs
  • IX. Principles and Techniques in Targeting
  • 21 Internalization ofAntibodies
  • 22 Bioconjugation and Biodistribution
  • 23 Principles of Antitumor Targeting of Cytotoxic Drugs
  • 24 Targeting by Antibody or Ligand: Which Is Better?